Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone suppositories versus Proluton ampoules for prevention of preterm birth
IRCT20251208068247N1Phase 4Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of progesterone and hydroxyprogesterone caproate in Preterm labor (PTL) and preterm birth (2 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoint: Prevention of premature birth. Started Dec 2025; status: completed.
02
Drugs
progesteronehydroxyprogesterone caproate
03
Conditions
Preterm labor (PTL)preterm birth
Beyond the preview
Go deeper on IRCT20251208068247N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251208068247N1.